Cancer Therapy Market Expected To Reach $342.09 Billion By 2030 As Growth Accelerates At 10.1% CAGR
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Cancer Therapy Market Size, Value And Growth Trends Through 2030
The cancer therapy market has experienced swift expansion in recent times, with projections indicating growth from $210.44 billion in 2025 to $232.47 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.5%. Several key factors drove this increase during the historic period, including a growing number of cancer cases, the widespread use of chemotherapy, enhanced hospital oncology facilities, the expansion of radiation therapy services, and the effects of an aging population.
The market for cancer therapies is anticipated to experience swift expansion over the coming years, reaching a valuation of $342.1 billion by 2030, progressing at a compound annual growth rate (CAGR) of 10.1%. This projected growth during the forecast period is driven by factors such as biomarker-guided treatments, an expanding immuno-oncology pipeline, the uptake of precision medicine, increasing healthcare spending, and enhanced early cancer detection capabilities. Key developments shaping this period include the swift integration of immunotherapy into clinical practice, the rise of targeted cancer interventions, the broadening scope of precision oncology, a growing emphasis on combined therapeutic approaches, and a notable trend toward customized treatment plans.
Download A Free Sample Report For Comprehensive Market Insights:
Cancer Therapy Market Development Factors: Which Trends Are Supporting Demand?
The anticipated rise in cancer cases is set to drive expansion in the cancer therapy market moving forward. Cancer encompasses a range of diseases marked by the unregulated growth and dissemination of abnormal cells within the body. This increase in cancer is largely attributed to heightened contact with environmental carcinogens like pollution and tobacco smoke. By treating current cases, enhancing survival rates, and slowing disease advancement, cancer therapy is instrumental in addressing the growing prevalence of the condition. As an example, in February 2024, the World Health Organization (WHO), an intergovernmental body headquartered in Switzerland, projected that global cancer incidence would surpass 35 million new cases by 2050—a 77% jump from the approximate 20 million cases reported in 2022. Consequently, the climbing incidence of cancer is fueling the cancer therapy market.
Cancer Therapy Market Segmentation Trends And Revenue Drivers
The cancer therapy market covered in this report is segmented –
1) By Therapy Type: Chemotherapy, Target Therapy, Immunotherapy, Radiotherapy, Other Therapy Types
2) By Cancer Type: Blood Cancer, Breast Cancer, Prostate Cancer, Gastrointestinal Cancer, Gynaecologic Cancer, Respiratory Or Lung Cancer, Other Cancer Types
3) By End User: Hospitals, Specialty Clinics, Cancer And Radiation Therapy Centers
Subsegments:
1) By Chemotherapy: Alkylating Agents, Antimetabolites, Anti-Tumor Antibiotics, Topoisomerase Inhibitors, Mitotic Inhibitors, Corticosteroids, Other Chemotherapy Drugs
2) By Targeted Therapy: Monoclonal Antibodies, Tyrosine Kinase Inhibitors (TKIs), mTOR Inhibitors, Proteasome Inhibitors, PARP Inhibitors, Other Targeted Agents
3) By Immunotherapy: Immune Checkpoint Inhibitors, CAR T-cell Therapy, Cancer Vaccines, Cytokines, Oncolytic Virus Therapy, Other Immunotherapies
4) By Radiotherapy: External Beam Radiation Therapy (EBRT), Internal Radiation Therapy (Brachytherapy), Systemic Radiation Therapy, Stereotactic Radiosurgery (SRS), Intensity-Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT)
5) By Other Therapy Types: Hormone Therapy, Stem Cell Transplant, Photodynamic Therapy, Cryoablation, Hyperthermia Therapy
Cancer Therapy Market Transformation Trends: Which Innovations Are Driving Change?
Within the cancer therapy market, key players are concentrating their efforts on the development of advanced treatment approaches, particularly immuno-oncology drugs, which are designed to improve therapeutic results by leveraging the body’s immune system to identify and eliminate cancer cells. These immuno-oncology agents represent a specific category of cancer treatments that work by either stimulating or enhancing the natural immune response, enabling it to more effectively recognize and attack malignant cells. A notable example of this trend occurred in December 2024, when Dr. Reddy’s Laboratories Ltd., a pharmaceutical company based in India, launched Toripalimab in the country. This drug is distinguished as the first and only immuno-oncology therapy approved for treating nasopharyngeal cancer, offering a novel and targeted treatment option for patients affected by this uncommon and aggressive form of the disease. By making Toripalimab available, Dr. Reddy’s is demonstrating a clear commitment to providing access to innovative cancer therapies in regions where such advanced treatments have often been limited.
Cancer Therapy Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the cancer therapy market are Pfizer Inc., Johnson & Johnson, F. Hoffmann-La Roche Ltd, Merck & Co. Inc., Bayer Aktiengesellschaft, Bristol-Myers Squibb Company, AstraZeneca PLC, Novartis International AG, GlaxoSmithKline PLC, Elekta AB, Exelixis Inc., Accuray Incorporated, Akeso Inc., Nanobiotix S.A., SOTIO Biotech a.s., AdvanCell Isotopes Pty Ltd, Axcynsis Therapeutics Pte Ltd, Clarity Pharmaceuticals Ltd, Affimed N.V., Aptadel Therapeutics S.L.
Access The Complete Cancer Therapy Market Report:
Cancer Therapy Market Regional Analysis: Which Region Leads By Revenue?
North America was the largest region in the cancer therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cancer therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
